NeuroGyn Genital Neuromodulation System for iOAB Treatment

Inclusion Criteria: * 18 years of age and older (adult and older adult, all sexes) * Diagnosed (urodynamic testing) with idiopathic overactive bladder (iOAB) * Symptoms of urinary urgency, frequency, and/or urge incontinence for at least 6 months * Failed conservative treatments (e.g., lifestyle modifications, medications) * Willing and capable of providing informed consent * Capable of participating in all testing associated with this clinical investigation * Patients have already undergo a successful GNS-test phase with adhesive electrodes (reduction symptoms greater equal or more than 50%) Exclusion Criteria: * History of pelvic surgery affecting the pubic bone or genital nerves * Current urinary tract infection * Neurological conditions affecting bladder function (neurogenic OAB) * Pregnancy or planning to become pregnant during the study period * Contraindications to local anesthesia or surgery * Female patients with significant prolapse (i.e., prolapse beyond the introitus). * Patients with primary stress incontinence and primary pelvic pain symptoms. * Patients with less than 12 months from last intravesical botulinum toxin A therapy * Patients with mechanical infravesical obstruction and/or Interstitial Cystitis. * Vulnerable patients with co-morbid conditions should be excluded from this study. These co-morbid conditions include all pathologies of the cardiovascular system (Angina Pectoris, Infarct, Thrombose, Embolie, Hypertonia), pulmonary system (asthma, COPD, …